Population pharmacokinetics of ceftazidime in critically ill children: impact of cystic fibrosis.

Bui S, Facchin A, Ha P, Bouchet S, Leroux S, Nacka F, Fayon M, Jacqz-Aigrain E

Open source

DOI
10.1093/jac/dkaa170
Published
2020 Aug 1
Container
The Journal of antimicrobial chemotherapy
Publisher
Not recorded
Open access
unknown

Credibility signals

limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1093/jac/dkaa170,
  title = {Population pharmacokinetics of ceftazidime in critically ill children: impact of cystic fibrosis.},
  author = {Bui S and Facchin A and Ha P and Bouchet S and Leroux S and Nacka F and Fayon M and Jacqz-Aigrain E},
  year = {2020},
  journal = {The Journal of antimicrobial chemotherapy},
  doi = {10.1093/jac/dkaa170},
  url = {https://doi.org/10.1093/jac/dkaa170}
}

RIS

TY  - JOUR
TI  - Population pharmacokinetics of ceftazidime in critically ill children: impact of cystic fibrosis.
AU  - Bui S
AU  - Facchin A
AU  - Ha P
AU  - Bouchet S
AU  - Leroux S
AU  - Nacka F
AU  - Fayon M
AU  - Jacqz-Aigrain E
PY  - 2020
JO  - The Journal of antimicrobial chemotherapy
DO  - 10.1093/jac/dkaa170
UR  - https://doi.org/10.1093/jac/dkaa170
ER  - 

APA

S, B., A, F., P, H., S, B., S, L., F, N., M, F., & E, J. (2020). Population pharmacokinetics of ceftazidime in critically ill children: impact of cystic fibrosis.. The Journal of antimicrobial chemotherapy. https://doi.org/10.1093/jac/dkaa170

Source records